Cargando…
Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer
BACKGROUND: The role of nicotinamide N-methyltransferase (NNMT) in ovarian cancer is still elusive. Our aim is to explore the expression of NNMT in ovarian cancer and to assess its association with patient prognosis and treatment response. METHODS: We first analyzed the differential expression of NN...
Autores principales: | Li, Jun, Yue, Huiran, Yu, Hailin, Lu, Xin, Xue, Xiaohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809740/ https://www.ncbi.nlm.nih.gov/pubmed/33446144 http://dx.doi.org/10.1186/s12885-021-07785-w |
Ejemplares similares
-
Bevacizumab confers significant improvements in survival for ovarian cancer patients with low miR-25 expression and high miR-142 expression
por: Li, Jun, et al.
Publicado: (2021) -
Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer
por: Li, Jun, et al.
Publicado: (2019) -
The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease
por: Takahashi, Rina, et al.
Publicado: (2022) -
Nicotinamide N-Methyltransferase in Health and Cancer
por: Ramsden, David B, et al.
Publicado: (2017) -
Nicotinamide N-methyltransferase and liver diseases
por: Liang, Guangyu, et al.
Publicado: (2022)